ESM1, also known as endocan, has been shown to regulate endothelial cell function in the initiation and progression of human cancers, including esophageal cancer, hepatocellular carcinoma, bladder cancer, and breast cancer (22). Here, ESM1 is linked to hepatocellular carcinoma.